Dr. Sanja Vranješ-Đurić, Principal Research Fellow (since 2012), currently serves as a Head of the Laboratory for radioisotopes (LR) in VINS (since 2016).
After receiving her BSc degree in Biochemistry (1993) she joined the LR. As a PhD fellow, she received a Swiss Confederation research grant award, completed PhD thesis at CERN and University Hospital Geneva (under the supervision of prof. Gerd–Jürgen Beyer on Swiss National Science Foundation Project No. 31-53672.98), and received PhD degree on Faculty of Chemistry at the University of Belgrade (2002). She has unique experience in the development of new radiopharmaceuticals based on both reactor’s and cyclotron’s radionuclides, especially in: synthesis of different organic compounds, nanoparticles (fullerenes, colloids, magnetic nanoparticles) and microspheres; optimization of the conditions for their radiolabelling with various radionuclides: gamma emitters (125I, 99mTc, 111In, 149Gd, 201Tl) for use in diagnosis and alpha (149Tb) and beta (Sm153, 131I, 90Y, 177Lu) emitters for use in radiotherapy; investigation of biochemical and biological properties of radiolabelled compounds (in vitro and in vivo tests). She has 49 peer-reviewed journal papers cited more than 1000 times (h-index = 19). List of publications available at https://orcid.org/0000-0002-6340-2387. Honors: Several annual awards of the Serbian Association of Nuclear Medicine for the special achievements in the development of radiopharmaceuticals (1997, 2000, 2009, 2019). Annual Award of the Vinča Institute for excellence in the field of applied research.